ABSI vs RXRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 08, 2026

ABSI

42.0
AI Score
VS
RXRX Wins

RXRX

59.7
AI Score

Investment Advisor Scores

ABSI

42score
Recommendation
HOLD

RXRX

60score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ABSI RXRX Winner
Revenue 3.87M 32.69M RXRX
Net Income -74.12M -367.55M ABSI
Net Margin -1915.8% -1124.2% RXRX
Operating Income -79.11M -386.65M ABSI
ROE -36.8% -40.6% ABSI
ROA -31.5% -30.1% RXRX
Total Assets 235.23M 1.22B RXRX
Cash 38.20M 549.85M RXRX
Current Ratio 5.63 5.01 ABSI
Free Cash Flow -55.82M -265.16M ABSI

Relative Price Performance (Last 90 Days)

ABSI 1M: +11.0% · 3M: +5.7% RXRX 1M: -8.3% · 3M: +8.5%

Current Technical Phase

ABSI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.4 · Price: $9.71

RXRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 43.4 · Price: $3.43

Fundamentals Snapshot

Metric ABSI RXRX
Market Cap — —
Forward P/E -14.6 -4.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.5% 2.6%
Gross Margin -54.0% -5.2%
Operating Margin -107.4% -6.6%
EPS -0.79 -0.86
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RXRX is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.